Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Operating activities
Net income	$ 172.4	$ 154.9
Income from discontinued operations, net of tax	(11.6)	0.0
Adjustments to reconcile net income from continuing operations to net cash provided by (used for) operating activities
Equity income of unconsolidated subsidiaries	(0.5)	(0.4)
Depreciation	14.6	14.8
Amortization	15.7	14.2
Deferred income taxes	1.8	11.5
Share-based compensation	15.7	12.6
Asset impairment and write-offs	0.0	5.2
Changes in assets and liabilities, net of effects of business acquisitions
Accounts receivable	(243.0)	(261.6)
Inventories	(11.5)	(3.5)
Other current assets	(6.6)	(12.5)
Accounts payable	33.5	23.8
Employee compensation and benefits	(24.5)	(24.3)
Other current liabilities	(23.7)	22.6
Other non-current assets and liabilities	0.3	3.8
Net cash used for operating activities	(67.4)	(38.9)
Net cash used for operating activities	(67.4)	(38.9)
Investing activities
Capital expenditures	(18.5)	(16.8)
Proceeds from sale of property and equipment	0.2	0.0
Net cash used for investing activities	(18.3)	(16.8)
Financing activities
Net repayments of short-term borrowings	0.0	(9.3)
Net borrowings of revolving long-term debt	304.9	196.2
Shares issued to employees, net of shares withheld	(10.2)	(8.6)
Repurchases of ordinary shares	(200.0)	(50.0)
Dividends paid	(44.1)	(41.2)
Net cash provided by financing activities	50.6	87.1
Effect of exchange rate changes on cash and cash equivalents	1.2	(9.5)
Change in cash and cash equivalents	(33.9)	21.9
Cash and cash equivalents, beginning of period	101.6	118.7
Cash and cash equivalents, end of period	$ 67.7	$ 140.6